Completed NA INTERVENTIONAL 3-arm NCT05090527

Penicillin Allergy Delabeling Project (PenProv)

Penicillin Delabeling With Help of a Risk Stratification Tool, Advanced Provocation Tests in a Non Allergologic Unit

Sponsor: Haraldsplass Deaconess Hospital

Updated 4 times since 2021 Last updated: Feb 7, 2024 Started: Jul 28, 2021 Primary completion: Apr 1, 2023 Completion: May 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Penicillin Allergy, this trial is completed. The trial is conducted by Haraldsplass Deaconess Hospital and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2024 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Nov 2021 — Mar 2024 [monthly]

Recruiting NA

First recorded

Jul 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Haraldsplass Deaconess Hospital
Haukeland University Hospital
Helse Fonna
Helse Forde
Helse Stavanger HF

Data source: Haukeland University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bergen, Norway
• Førde, Norway